Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pediatric hypothalamic obesity.

Trial Profile

Pediatric hypothalamic obesity.

Phase of Trial: Phase II

Latest Information Update: 09 Sep 2011

At a glance

  • Drugs Octreotide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 09 Sep 2011 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
    • 29 Sep 2009 Planned number of patients changed from 50 to 60 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top